Martingale Asset Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-71,419
| Closed | -$2.34M | – | 926 |
|
|
2022
Q2 | $2.34M | Sell |
71,419
-10,363
| -13% | -$328K | 0.04% | 236 |
|
|
2022
Q1 | $2.15M | Sell |
81,782
-206
| -0.3% | -$5.03K | 0.03% | 270 |
|
|
2021
Q4 | $1.95M | Sell |
81,988
-6,095
| -7% | -$150K | 0.02% | 316 |
|
|
2021
Q3 | $2.21M | Buy |
88,083
+23,801
| +37% | +$606K | 0.03% | 273 |
|
|
2021
Q2 | $1.67M | Sell |
64,282
-4,199
| -6% | -$114K | 0.02% | 279 |
|
|
2021
Q1 | $1.75M | Sell |
68,481
-898
| -1% | -$23K | 0.02% | 294 |
|
|
2020
Q4 | $1.39M | Sell |
69,379
-86,698
| -56% | -$1.7M | 0.02% | 368 |
|
|
2020
Q3 | $2.67M | Sell |
156,077
-72,476
| -32% | -$1.37M | 0.03% | 350 |
|
|
2020
Q2 | $4.99M | Buy |
228,553
+45,611
| +25% | +$1.04M | 0.06% | 308 |
|
|
2020
Q1 | $4.23M | Buy |
182,942
+6,400
| +4% | +$186K | 0.06% | 334 |
|
|
2019
Q4 | $5.83M | Buy |
176,542
+1,700
| +1% | +$54.5K | 0.06% | 349 |
|
|
2019
Q3 | $5.57M | Buy |
174,842
+14,818
| +9% | +$432K | 0.06% | 354 |
|
|
2019
Q2 | $4.11M | Buy |
160,024
+18,201
| +13% | +$464K | 0.04% | 423 |
|
|
2019
Q1 | $3.6M | Buy |
141,823
+119,918
| +547% | +$3.58M | 0.04% | 457 |
|
|
2018
Q4 | $746K | Buy |
+21,905
| New | +$712K | 0.01% | 800 |
|
|
2017
Q4 | – | Sell |
-13,502
| Closed | -$507K | – | 1007 |
|
|
2017
Q3 | $507K | Sell |
13,502
-26,111
| -66% | -$922K | 0.01% | 833 |
|
|
2017
Q2 | $1.48M | Sell |
39,613
-58,111
| -59% | -$2.1M | 0.02% | 632 |
|
|
2017
Q1 | $3.84M | Sell |
97,724
-6
| -0% | -$225 | 0.06% | 362 |
|
|
2016
Q4 | $3.4M | Buy |
97,730
+6,401
| +7% | +$251K | 0.05% | 420 |
|
|
2016
Q3 | $3.59M | Buy |
91,329
+85,106
| +1,368% | +$3.39M | 0.05% | 361 |
|
|
2016
Q2 | $236K | Sell |
6,223
-16,415
| -73% | -$550K | ﹤0.01% | 784 |
|
|
2016
Q1 | $870K | Sell |
22,638
-1
| -0% | -$37 | 0.02% | 544 |
|
|
2015
Q4 | $1.09M | Sell |
22,639
-403
| -2% | -$18.7K | 0.02% | 458 |
|
|
2015
Q3 | $910K | Sell |
23,042
-3,620
| -14% | -$154K | 0.02% | 506 |
|
|
2015
Q2 | $1.14M | Sell |
26,662
-570
| -2% | -$22.7K | 0.03% | 479 |
|
|
2015
Q1 | $1.07M | Sell |
27,232
-950
| -3% | -$35K | 0.03% | 496 |
|
|
2014
Q4 | $1.02M | Buy |
28,182
+11,459
| +69% | +$385K | 0.03% | 524 |
|
|
2014
Q3 | $494K | Buy |
16,723
+7,623
| +84% | +$210K | 0.02% | 673 |
|
|
2014
Q2 | $229K | Buy |
+9,100
| New | +$225K | 0.01% | 829 |
|
Other funds holding NTUS
Martingale Asset Management's NTUS Position: Q3 2022 in Review
Martingale Asset Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 71,419 shares — an estimated $2.34M sold.
Martingale Asset Management first reported a position in NTUS in Q2 2014 and held it in 29 quarters. The position peaked at $5.83M in Q4 2019. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Martingale Asset Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Martingale Asset Management sold 71,419 Natus Medical Inc shares in Q3 2022, an estimated $2.34M.
- Martingale Asset Management first reported a position in Natus Medical Inc in Q2 2014 and held it in 29 quarters.
- Martingale Asset Management's Natus Medical Inc position peaked at $5.83M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Martingale Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.